We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Insights Into Tenet (THC) Q3: Wall Street Projections for Key Metrics
Read MoreHide Full Article
The upcoming report from Tenet Healthcare (THC - Free Report) is expected to reveal quarterly earnings of $4.60 per share, indicating an increase of 24.3% compared to the year-ago period. Analysts forecast revenues of $5.47 billion, representing an increase of 3.5% year over year.
The current level reflects a downward revision of 0.1% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
Given this perspective, it's time to examine the average forecasts of specific Tenet metrics that are routinely monitored and predicted by Wall Street analysts.
Analysts expect 'Net Operating revenues- Hospital Operations and Services' to come in at $4.09 billion. The estimate indicates a year-over-year change of +1.9%.
The combined assessment of analysts suggests that 'Net Operating revenues- Ambulatory Care' will likely reach $1.38 billion. The estimate indicates a year-over-year change of +8.4%.
Based on the collective assessment of analysts, 'Net Operating revenues' should arrive at $5.47 billion. The estimate indicates a change of +3.5% from the prior-year quarter.
The collective assessment of analysts points to an estimated 'Adjusted patient admissions - Same-hospital' of 216.15 thousand. Compared to the present estimate, the company reported 212.37 thousand in the same quarter last year.
The consensus among analysts is that 'Net patient service revenue per adjusted patient admission - Same Hospital' will reach $16424.59 . The estimate is in contrast to the year-ago figure of $16068.00 .
It is projected by analysts that the 'Adjusted admissions' will reach 213.91 thousand. Compared to the present estimate, the company reported 215.46 thousand in the same quarter last year.
According to the collective judgment of analysts, 'Equity in earnings of unconsolidated affiliates' should come in at $67.93 million. Compared to the present estimate, the company reported $64.00 million in the same quarter last year.
The consensus estimate for 'Adjusted EBITDA- Hospital Operations and Services' stands at $629.45 million. The estimate is in contrast to the year-ago figure of $607.00 million.
Analysts' assessment points toward 'Adjusted EBITDA- Ambulatory Care' reaching $537.76 million. Compared to the current estimate, the company reported $492.00 million in the same quarter of the previous year.
The average prediction of analysts places 'Equity in earnings of unconsolidated affiliates- Ambulatory Care' at $67.91 million. Compared to the current estimate, the company reported $63.00 million in the same quarter of the previous year.
Shares of Tenet have demonstrated returns of +4.3% over the past month compared to the Zacks S&P 500 composite's -0.8% change. With a Zacks Rank #3 (Hold), THC is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
View the Zacks #1 Rank List
Image: Bigstock
Insights Into Tenet (THC) Q3: Wall Street Projections for Key Metrics
The upcoming report from Tenet Healthcare (THC - Free Report) is expected to reveal quarterly earnings of $4.60 per share, indicating an increase of 24.3% compared to the year-ago period. Analysts forecast revenues of $5.47 billion, representing an increase of 3.5% year over year.
The current level reflects a downward revision of 0.1% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
Given this perspective, it's time to examine the average forecasts of specific Tenet metrics that are routinely monitored and predicted by Wall Street analysts.
Analysts expect 'Net Operating revenues- Hospital Operations and Services' to come in at $4.09 billion. The estimate indicates a year-over-year change of +1.9%.
The combined assessment of analysts suggests that 'Net Operating revenues- Ambulatory Care' will likely reach $1.38 billion. The estimate indicates a year-over-year change of +8.4%.
Based on the collective assessment of analysts, 'Net Operating revenues' should arrive at $5.47 billion. The estimate indicates a change of +3.5% from the prior-year quarter.
The collective assessment of analysts points to an estimated 'Adjusted patient admissions - Same-hospital' of 216.15 thousand. Compared to the present estimate, the company reported 212.37 thousand in the same quarter last year.
The consensus among analysts is that 'Net patient service revenue per adjusted patient admission - Same Hospital' will reach $16424.59 . The estimate is in contrast to the year-ago figure of $16068.00 .
It is projected by analysts that the 'Adjusted admissions' will reach 213.91 thousand. Compared to the present estimate, the company reported 215.46 thousand in the same quarter last year.
According to the collective judgment of analysts, 'Equity in earnings of unconsolidated affiliates' should come in at $67.93 million. Compared to the present estimate, the company reported $64.00 million in the same quarter last year.
The consensus estimate for 'Adjusted EBITDA- Hospital Operations and Services' stands at $629.45 million. The estimate is in contrast to the year-ago figure of $607.00 million.
Analysts' assessment points toward 'Adjusted EBITDA- Ambulatory Care' reaching $537.76 million. Compared to the current estimate, the company reported $492.00 million in the same quarter of the previous year.
The average prediction of analysts places 'Equity in earnings of unconsolidated affiliates- Ambulatory Care' at $67.91 million. Compared to the current estimate, the company reported $63.00 million in the same quarter of the previous year.
View all Key Company Metrics for Tenet here>>>Shares of Tenet have demonstrated returns of +4.3% over the past month compared to the Zacks S&P 500 composite's -0.8% change. With a Zacks Rank #3 (Hold), THC is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .